W R Grace & Co (GRA) said that its board of directors has elected Shlomo Yanai as an independent director.
Yanai currently is chairman of the Cambrex Corporation, chairman of Protalix Biotherapeutics, and a senior advisor to Moelis & Company. He served as president and chief executive officer (CEO) of Teva Pharmaceutical Industries Ltd from 2007 until mid-2012, leading a period of significant growth in revenue and profitability.
As Teva CEO, Yanai was ranked 20th in Fortune's Top CEO List in 2010. Prior to joining Teva, Yanai was president and CEO of Makhteshim-Agan Industries Ltd. Yanai served for 32 years with the Israeli Defense Forces and retired in 2001 as a major general.
W R Grace & Co (GRA) said that its board of directors has elected Shlomo Yanai as an independent director.
Yanai currently is chairman of the Cambrex Corporation, chairman of Protalix Biotherapeutics, and a senior advisor to Moelis & Company. He served as president and chief executive officer (CEO) of Teva Pharmaceutical Industries Ltd from 2007 until mid-2012, leading a period of significant growth in revenue and profitability.
As Teva CEO, Yanai was ranked 20th in Fortune's Top CEO List in 2010. Prior to joining Teva, Yanai was president and CEO of Makhteshim-Agan Industries Ltd. Yanai served for 32 years with the Israeli Defense Forces and retired in 2001 as a major general.
No comments:
Post a Comment